Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Liraglutide (marketed as Victoza for diabetes, Saxenda for obesity) was the first GLP-1 agonist approved for chronic weight management (FDA 2014), while semaglutide (Ozempic/Wegovy/Rybelsus) arrived later with improved pharmacokinetics and substantially greater efficacy
We feel like we have an incredibly strong case on the health economics, he said
OTC Option: Combine an osmotic (Miralax) to get things moving, plus an otc stool softener for adults (Colace) to make it comfortable to pass
All FDA-approved GLP-1 receptor agonists require a prescription because they are classified as drugs, not supplements, and require clinical evaluation for safe prescribing
US$ 21.06
US$ 29.65
US$ 28.93
US$ 28.74
US$ 26.78
